Intraluminal fat inhibits gastric secretion through as yet undetermined mechanisms which involve release of one or more hormonal enterogastrones. As intraluminal fat releases Peptide YY (PYY) in amounts sufficient to inhibit meal-stimulated acid secretion, this ileocolonic peptide exhibits the characteristics required of an enterogastrone. The present study seeks to determine the mechanism by which PYY inhibits acid secretion by examining the effects of PYY on gastric acid stimulated by pentagastrin, histamine, and bethanechol. In addition, effects of PYY on the acid response to sham feeding and distention of a denervated gastric pouch were examined. A dose of PYY (400 pmol X kg-1 X h-1) was employed that reproduced blood levels observed after intestinal perfusion with oleic acid and inhibited the acid secretory response to an intragastric meal by 35 +/-6%. This same dose of PYY maximally inhibited histamine-and pentagastrin-stimulated acid secretion by 28 +/-7% (P less than 0.05), and 17 +/-4% (P less than 0.05), respectively. Although PYY had no effect on bethanechol-stimulated secretion it markedly inhibited the secretory response to sham feeding, maximally reducing secretion by 90 +/-4% (P less than 0.01). We speculate that PYY acts by inhibiting acetylcholine release from vagal nerve fibers rather than by inhibiting acetylcholine's action on the parietal cell. 
Introduction
In 1886, Ewald and Boas (1) noted that addition of olive oil to a test meal of gruel depressed acid secretion in human subjects. Workers in Pavlov's laboratory demonstrated that this phenomenon could only be demonstrated if fat was allowed to pass beyond the stomach (2) . Subsequent studies by Lim and coworkers (3, 4) demonstrated that this response was at least in part hormonally mediated and could be reproduced by the injection of crude mucosal extracts of both the small and large intestine. Despite their observation that colonic extracts were as potent as jejunal extracts, the search for enterogastrones has largely centered on the mucosa of the small intestine. However, increased interest in the colon as an endocrine organ has been engendered by studies (5) (6) (7) that demonstrate inhibition ofgastric secretion after perfusion of the colon with a variety of nutrients, including fat.
Recently, a peptide isolated (8, 9 ) from porcine intestinal mucosa (Peptide YY) has been demonstrated to inhibit mealstimulated acid secretion (10) . Peptide YY (PYY)' is present in highest concentrations in the mucosa of the ileum and colon where it is localized to endocrine-like cells (1 1) . The demonstration that PYY is released into the circulation after ingestion of a meal (12) suggests a hormonal action for this peptide. A role for PYY as an enterogastrone is supported by the demonstration that blood levels observed after intestinal perfusion with oleic acid are capable of inhibiting meal-stimulated acid secretion (10) . To examine the mechanism(s) by which PYY inhibits acid secretion, we studied the effects of exogenously infused synthetic PYY on gastric acid stimulated by pentagastrin, histamine, and bethanechol. A dose of PYY (400 pmol -kg-' -h-') was chosen based on the prior demonstration that it reproduced blood levels observed after intestinal perfusion with oleic acid and significantly inhibited meal-stimulated acid secretion (10) . In addition, we examined the effects ofthis dose of PYY on the acid secretory responses to both sham feeding and distention of a denervated gastric pouch. Finally, we tested the effects of PYY on mealstimulated gastrin release to determine if PYY exerts its inhibitory effect on acid secretion through inhibition ofgastrin release.
Methods
Animals. A total of thirteen dogs were prepared variously with gastric fistula, esophageal fistula, or Heidenhain pouches using previously published methods (10, 13, 14) . The esophageal fistula was created in a twostage operation mobilizing the esophagus into a skin tunnel at the neck. The Heidenhain pouches were vagally denervated and created as a 30-ml pouch from the greater fundic curvature. Gregory cannulas drained the pouch to the surface ofthe anterior abdominal wall. Dogs were allowed several weeks to recover before study. During this time they were maintained on dog chow (Ralston Purina Co., Chow Div., St. Louis, MO) and then deprived of food, but not water, for 18 h before each study.
Effect ofPYY on meal-stimulated acid secretion and gastrin release.
Four gastric fistula dogs were infused with either intravenous saline or PYY (400 pmol-kg-' -h-') I h before and I h after the intragastric instillation of a 300-ml, 15% liver extract meal. The acid response to this meal was monitored by intragastric titration using 0.2 N NaOH to maintain a constant intraluminal pH of 5.5 (15) . In separate studies blood samples were drawn before and 30 and 60 min after intragastric instillation of the liver-extract meal during infusion of the saline carrier or 400 pmol -kg-' -h-' PYY. Bloods were drawn into calcium oxalate tubes containing 500 U/ml trasylol. Plasma samples were assayed for gastrin (16) and PYY (12) Statistics. All data are expressed as mean±1 SE. Differences between responses with and without infusion of PYY were determined by a Student's paired two-tailed t test. A P < 0.05 was determined as significant.
Results
Effect of PYY on meal-stimulated acid secretion. The acid secretory response to the 15% liver extract meal plateaued during the last 30 min of the study hour. The mean acid output 45 min after introduction of the meal was 6.74±1.59 mmol HCI/l 5 min and 6.90±1.70 mmol HCI/l 5 min at 60 min. PYY (400 pmol -kg-' * h-') significantly inhibited (P < 0.05) the acid secretory response to the meal 15, 30, and 45 min after instillation ofthe meal (Fig. 1) . The inhibitory effect of PYY did not achieve statistical significance over the final 15-min period of the study hour. Meal-stimulated acid secretion was maximally inhibited by 35±6% (P < 0.05).
Effect of PYY on meal-stimulated gastrin release. Serum gastrin responses to the liver extract meal during saline and PYY infusion are shown in Fig. 2 . PYY infusion had no significant effect on basal gastrin concentrations. Gastrin responses to the meal were numerically higher during the PYY infusion but this difference did not achieve statistical significance. The (Fig. 6) .
Effect ofPYY on the acid response to Heidenhain distention. Distention of the Heidenhain pouch resulted in a pressure-dependent increase in acid secretion. 20 cm of pressure resulted in a mean acid output of 180.0±7.9 ,mol/30 min (Fig. 7) . The 400 pmol kg-' h-' dose of PYY only inhibited distentionstimulated acid secretion significantly (P < 0.05) when the lowest distention pressure (5 cm H20) was applied. No Histamine p~g/kg/h Figure 4 . Effects of PYY (400 pmol * kg-' -h-t) on the acid secretory response to histamine.
Peptide YY is a newly discovered member of the pancreatic polypeptide (PP) family that shares 50% homology with the founding member, PP (8, 9, 17) . Although structurally related, the distribution of each peptide in the body differs markedly. PP is restricted almost totally to the pancreas (17) while PYY is found in highest concentrations (9, 11, 12) (10) and is capable ofinhibiting acid secretion (10) and delaying gastric emptying (18) .
In the present study we observed that a 400 pmol * kg-' * hdose of PYY inhibited the acid secretory response to an intragastric meal by approximately one-third. The mean increment in PYY concentrations under these circumstances (429±18 pM) represents the summation of the response to the liver extract meal and the infusion of exogenous PYY. However, this increase in circulating PYY concentrations is similar to that observed previously (10) after intestinal perfusion with oleic acid (403±63 pM). Although we observed that PYY inhibited meal-stimulated acid secretion by 35±6%, others (3, 4) have observed 90-100% inhibition of meal-stimulated acid secretion after instillation of 50 cm3 of olive oil into the stomach or colon (4) . In addition, meal-stimulated acid secretion is inhibited by as much as 72% after injection of crude extracts of jejunal and colonic mucosa. Although we had previously (10) observed that a 800 pmol *kg-' * h-' dose of PYY inhibited meal-stimulated acid secretion by 71%, this dose consistently caused retching. As such, this larger dose of PYY may have caused more profound inhibition of acid secretion by inducing nausea. Historically (2) induction of nausea by fat has been a complicating factor in defining the physiological characteristics of enterogastrone. Thus, fat-induced nausea may serve to explain (2) previous reports that enterogastrone is capable of inhibiting histamine-stimulated acid secretion. Nausea due to high fat loads may also explain the great variability in the degree of fat-induced inhibition of acid secretion (ranging from 20 to 100%), reported in the literature (4, 19) .
The early studies of Kosaka and Lim (4, 20) 47% of the acid response to an ingested meal in the first hour and 11% of the response in the second hour. Cephalic-vagal stimulation potentiates acid secretion during other phases of the meal response. In particular it enhances secretory responses to gastric distention and intraluminal nutrients (23) . Because of these potentiating interactions, removal of the cephalic-vagal phase of acid secretory response might have a disproportionate effect on the total secretory response to food. We speculate that PYY also inhibits the gastric phase of acid secretion directly by inhibiting long vago-vagal reflexes that in part mediate this response (23) . This would explain PYY's ability to inhibit the acid secretory response to a meal instilled directly into the stomach, a situation in which the cephalic phase is largely bypassed. For these reasons we would predict that PYY would be a more potent inhibitor of the acid secretory response to an ingested meal where both the cephalic and gastric phases are operative.
In summary, we have demonstrated that PYY is a potent inhibitor of cephalic phase acid secretion and suggest that it acts through the vagus by inhibiting acetylcholine release. The present observations call into question the historic criteria used to define hormonal actions. Thus, a biological action that persists after denervation of the target organ is held to be hormonally mediated. Conversely, an action that is abolished by denervation of the target organ is said to be neurally mediated. Our findings with PYY suggest that the actions of some gastrointestinal peptides are so intimately connected with the actions of the autonomic nervous system that they cannot be so easily differentiated.
